Vistelle R, Lamiable D, Morin E, Trenque T, Kaltenbach M
Laboratoire de Pharmacologie et Pharmacocinétique, U.F.R. de Pharmacie, Reims, France.
Drug Metab Dispos. 1995 Sep;23(9):988-92.
The metabolism of (+)-cicletanine and (-)-cicletanine (10 mg kg-1) was studied in healthy male Wistar rats 24 hr after a single dose and following daily oral administration for 25 days. Urine, collected in 24-hr intervals on days 1, 5, 10, 15, 20, and 25, was analyzed by an HPLC method for parent drug and its sulfate/glucuronide conjugates. In urine, the sulfate and glucuronide conjugates of cicletanine were the only two major components quantitated; parent drug was a minor component. Within 24 hr after the first dose of (+)-cicletanine, the sulfate conjugate was the major urinary component; the ratio of sulfate to glucuronide conjugate was 3. After oral administration of (-)-cicletanine, the glucuronide and sulfate conjugates were present in similar amounts. For each enantiomer, the ratio of sulfate/glucuronide did not change upon multiple dosing, and inversion of the enantiomers did not occur. Although sulfate and glucuronide conjugates of each enantiomer are formed, the relative amounts of each conjugate depends on the enantiomer, indicating that there is stereospecificity in the disposition of cicletanine.
在健康雄性Wistar大鼠中,研究了单剂量给药24小时后以及每日口服给药25天后,(+)-西氯他宁和(-)-西氯他宁(10 mg/kg)的代谢情况。在第1、5、10、15、20和25天,每隔24小时收集尿液,采用高效液相色谱法分析母体药物及其硫酸盐/葡萄糖醛酸结合物。在尿液中,西氯他宁的硫酸盐和葡萄糖醛酸结合物是仅有的两个可定量的主要成分;母体药物是次要成分。在首次给予(+)-西氯他宁后的24小时内,硫酸盐结合物是主要的尿液成分;硫酸盐与葡萄糖醛酸结合物的比例为3。口服(-)-西氯他宁后,葡萄糖醛酸结合物和硫酸盐结合物的含量相似。对于每种对映体,多次给药后硫酸盐/葡萄糖醛酸的比例没有变化,且对映体没有发生转化。虽然每种对映体都形成了硫酸盐和葡萄糖醛酸结合物,但每种结合物的相对含量取决于对映体,这表明西氯他宁的处置存在立体特异性。